Efficacy of Tokishakuyakusan add‐on therapy with low‐dose oral contraceptive pills on endometriosis patients with dysmenorrhea

2020 ◽  
Vol 46 (11) ◽  
pp. 2280-2286
Author(s):  
Fuminori Taniguchi ◽  
Yohei Tokita ◽  
Ikuko Ota ◽  
Emiko Yamane ◽  
Hiroaki Komatsu ◽  
...  
Keyword(s):  
Oral Contraceptive ◽  
Low Dose ◽  
Oral Contraceptive Pills ◽  
Contraceptive Pills ◽  
Dose Oral ◽  
Dose Oral Contraceptive

Urinary hormonal profile during the first cycle of low-dose oral contraceptive pills in women

Contraception ◽  
1990 ◽  
Vol 42 (1) ◽  
pp. 29-34
Author(s):  
Mahmoud Abou Ollo ◽  
Hassan El Sokkary ◽  
Emad Darwish ◽  
Yousry Khamis ◽  
Abdel Razek Souka
Keyword(s):  
Oral Contraceptive ◽  
Low Dose ◽  
Oral Contraceptive Pills ◽  
Hormonal Profile ◽  
Contraceptive Pills ◽  
Dose Oral ◽  
Dose Oral Contraceptive

scholarly journals Efficacy and Safety of Ultra Low Dose Oral Contraceptive Pills in Rural Indian Women - A Prospective, Open Label Study

2021 ◽  
Vol 8 (11) ◽  
pp. 618-622
Author(s):  
Sheela Raghavendra Sharma
Keyword(s):  
Oral Contraceptive ◽  
Side Effects ◽  
Low Dose ◽  
Ethinyl Estradiol ◽  
Indian Women ◽  
Oral Contraceptive Pills ◽  
Combined Oral Contraceptive ◽  
Contraceptive Pills ◽  
Dose Oral ◽  
Dose Oral Contraceptive

BACKGROUND Combined oral contraceptive pills are the most effective temporary contraception methods and are used by approximately 60 - 80 million eligible women throughout the world. It is the oestrogen component of the combined oral contraceptive (COC) which is responsible for the undesirable and serious side effects such as deep vein thrombosis (DVT) and pulmonary embolism (PE). So, there has been a constant effort to reduce the amount of ethinyl estradiol (EE) while maintaining its contraceptive efficacy. This study was aimed at studying the safety and efficacy of ultralow dose combined oral contraceptive (containing 15 mcg EE + 60 mcg gestodene) in rural Indian women. METHODS The study was done at Rama Medical College, Mandhana, Kanpur, among 70 patients who fulfilled the inclusion criteria. The patients were given ULDOCP and followed up for 6 months. The patients followed the regime of one tablet of ULDOCP daily from day 1 to day 24 of the menstrual cycle with 4 days pill free period before starting the next pack. RESULTS Seventy patients completed the study till 3 months and fifty patients completed the study till 6 months. Break through bleeding (BTB) was the only prominent side effect which was reduced in subsequent cycles and our patients tolerated this well. No pregnancy resulted. The ULDCOP was very well accepted by those women who were counselled about possible side effects and their harmless nature before starting the study. It was found that the users were satisfied with the use of ULDOCP. All side effects were significantly lower after 2 months of use and there were no serious side effects. CONCLUSIONS The 24 / 4 ULDOCP regimen seems to be a safe and effective contraceptive method for use in rural population after properly counselling them. The reduced pill free interval of 4 days offered additional advantages. KEYWORDS Ultra-Low Dose Oral Contraceptive Pills (ULDOCP), Ethinyl Estradiol (EE), Safe Contraception, Gestodene, BTB (Break Through Bleeding)

How effective are ultra-low dose oral contraceptive pills for treatment of benign ovarian cysts?

2003 ◽  
Vol 80 ◽  
pp. 218-219 ◽  
Author(s):  
Esra B. Kilicdag ◽  
Ebru Tarim ◽  
Serkan Erkanli ◽  
Erdogan Aslan ◽  
Gul Asik ◽  
...  
Keyword(s):  
Oral Contraceptive ◽  
Low Dose ◽  
Ovarian Cysts ◽  
Oral Contraceptive Pills ◽  
Contraceptive Pills ◽  
Dose Oral ◽  
Dose Oral Contraceptive

Use of a low-dose oral contraceptive containing norethindrone acetate and ethinyl estradiol in the treatment of moderate acne vulgaris

2001 ◽  
Vol 1 (3) ◽  
pp. 123-131 ◽  
Author(s):  
J. Michael Maloney ◽  
Deborah I. Arbit ◽  
Mary Flack ◽  
Constance McLaughlin-Miley ◽  
Cynthia Sevilla ◽  
...  
Keyword(s):  
Oral Contraceptive ◽  
Low Dose ◽  
Ethinyl Estradiol ◽  
Acne Vulgaris ◽  
Dose Oral ◽  
Dose Oral Contraceptive ◽  
Norethindrone Acetate

Clinical experience with a modern low-dose oral contraceptive in almost 100,000 users

Contraception ◽  
1991 ◽  
Vol 43 (2) ◽  
pp. 101-110 ◽  
Author(s):  
Klaus Brill ◽  
Thomas Norpoth ◽  
Jörg Schnitker ◽  
Manfred Albring
Keyword(s):  
Oral Contraceptive ◽  
Clinical Experience ◽  
Low Dose ◽  
Dose Oral ◽  
Dose Oral Contraceptive

Use of a monophasic, low-dose oral contraceptive in relation to mental functioning

Contraception ◽  
1992 ◽  
Vol 46 (4) ◽  
pp. 359-367 ◽  
Author(s):  
J.B. Deijen ◽  
K.J. Duyn ◽  
W.A. Jansen ◽  
J.W. Klitsie
Keyword(s):  
Oral Contraceptive ◽  
Low Dose ◽  
Mental Functioning ◽  
Dose Oral ◽  
Dose Oral Contraceptive

Comparison of the lipoprotein and hemostatic changes after a triphasic and a monophasic low dose oral contraceptive in premenopausal middle-aged women

1990 ◽  
Vol 84 (2-3) ◽  
pp. 203-211 ◽  
Author(s):  
Cesare R. Sirtori ◽  
Laura Calabresi ◽  
Guido Franceschini ◽  
Gemma Gianfranceschi ◽  
Francesco Zoppi ◽  
...  
Keyword(s):  
Oral Contraceptive ◽  
Low Dose ◽  
Middle Aged ◽  
Dose Oral ◽  
Dose Oral Contraceptive
Sign in / Sign up

Export Citation Format

Share Document